We encourage you to read the article "Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications", co-authored by Magdalena Wladysiuk, Vice President of HTA Consulting.
We encourage you to read the publication available in Frontiers in Pharmacology, co-authored by Robert Plisko, president of HTA Consulting: "The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures".Full text of the
We encourage you to read the article "Indirect costs of atopic dermatitis (AD) - systematic review and Polish perspective" published by JHPOR. The authors included Robert Plisko and Magdalena Władysiuk from HTA Consulting.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.